三鑫医疗：公司积极把握“中国智造”密集出海的历史机遇

Core Viewpoint - The company is accelerating its internationalization process and capitalizing on the historical opportunity of "Chinese manufacturing" going global, achieving significant growth in overseas markets [1] Group 1: International Expansion - The company has successfully completed product registrations in Indonesia, Peru, and Mexico, and is advancing certification processes in Turkey, Vietnam, and Brazil [1] - Over 100 products have obtained overseas registration certificates, enhancing the company's global competitiveness and laying a solid foundation for brand globalization [1] Group 2: Financial Performance - Overseas business revenue reached 187 million yuan, representing a year-on-year growth of 67.30% [1] - Blood purification product exports accounted for 88% of total export revenue, with sales revenue of 165 million yuan, up 83.84% year-on-year [1] - Export sales revenue for blood dialysis equipment increased by approximately 130%, while sales revenue for blood dialysis consumables grew by about 70% [1] Group 3: Future Strategy - The company plans to accelerate the self-certification process in more countries and strengthen deep cooperation with key customers to further expand overseas markets [1]